Kjersti Julin

440 total citations
14 papers, 343 citations indexed

About

Kjersti Julin is a scholar working on Molecular Biology, Pharmaceutical Science and Infectious Diseases. According to data from OpenAlex, Kjersti Julin has authored 14 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Pharmaceutical Science and 3 papers in Infectious Diseases. Recurrent topics in Kjersti Julin's work include Advancements in Transdermal Drug Delivery (3 papers), Bacterial biofilms and quorum sensing (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). Kjersti Julin is often cited by papers focused on Advancements in Transdermal Drug Delivery (3 papers), Bacterial biofilms and quorum sensing (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). Kjersti Julin collaborates with scholars based in Norway, Netherlands and India. Kjersti Julin's co-authors include Nataša Škalko‐Basnet, Mona Johannessen, Lill‐Heidi Johansen, Purusotam Basnet, Sybil Obuobi, Elizabeth G. Aarag Fredheim, May Wenche Jøraholmen, Jorunn B. Jørgensen, Željka Vanić and Stefan Krauß and has published in prestigious journals such as Nature Communications, Journal of Controlled Release and Frontiers in Microbiology.

In The Last Decade

Kjersti Julin

12 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kjersti Julin Norway 10 92 83 83 80 45 14 343
Naser Mohammadpour Dounighi Iran 10 219 2.4× 150 1.8× 140 1.7× 181 2.3× 71 1.6× 20 622
Hossein Zolfagharian Iran 12 158 1.7× 100 1.2× 43 0.5× 124 1.6× 36 0.8× 30 547
Yongsheng Ma China 7 124 1.3× 80 1.0× 45 0.5× 24 0.3× 75 1.7× 10 523
Chelsea L. Bueter United States 4 193 2.1× 83 1.0× 175 2.1× 34 0.4× 19 0.4× 7 432
Kyle Kleinbeck United States 11 110 1.2× 50 0.6× 33 0.4× 18 0.2× 35 0.8× 20 468
Patricia Pérez Esteban United Kingdom 8 166 1.8× 70 0.8× 26 0.3× 21 0.3× 117 2.6× 13 536
Melahat Bağırova Türkiye 14 130 1.4× 93 1.1× 88 1.1× 42 0.5× 108 2.4× 39 674
Grzegorz Gorczyca Poland 7 87 0.9× 136 1.6× 17 0.2× 17 0.2× 79 1.8× 10 357
Soheila Moradi Bidhendi Iran 10 94 1.0× 26 0.3× 44 0.5× 51 0.6× 33 0.7× 48 370
James Jung United States 10 164 1.8× 18 0.2× 31 0.4× 68 0.8× 37 0.8× 16 434

Countries citing papers authored by Kjersti Julin

Since Specialization
Citations

This map shows the geographic impact of Kjersti Julin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kjersti Julin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kjersti Julin more than expected).

Fields of papers citing papers by Kjersti Julin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kjersti Julin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kjersti Julin. The network helps show where Kjersti Julin may publish in the future.

Co-authorship network of co-authors of Kjersti Julin

This figure shows the co-authorship network connecting the top 25 collaborators of Kjersti Julin. A scholar is included among the top collaborators of Kjersti Julin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kjersti Julin. Kjersti Julin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Woods, Emily C., Kjersti Julin, Daniel Abegg, et al.. (2025). Identification of covalent inhibitors of Staphylococcus aureus serine hydrolases important for virulence and biofilm formation. Nature Communications. 16(1). 5046–5046.
3.
Julin, Kjersti, et al.. (2023). Exploring differentially expressed genes of Staphylococcus aureus exposed to human tonsillar cells using RNA sequencing. BMC Microbiology. 23(1). 185–185. 1 indexed citations
4.
Julin, Kjersti, Annette Bayer, Morten B. Strøm, et al.. (2023). Polymyxin B stabilized DNA micelles for sustained antibacterial and antibiofilm activity against P. aeruginosa. Journal of Materials Chemistry B. 11(33). 7972–7985. 8 indexed citations
5.
Julin, Kjersti, et al.. (2022). Chitosan-based delivery system enhances antimicrobial activity of chlorhexidine. Frontiers in Microbiology. 13. 1023083–1023083. 24 indexed citations
6.
Obuobi, Sybil, et al.. (2021). Biofilm Responsive Zwitterionic Antimicrobial Nanoparticles to Treat Cutaneous Infection. Biomacromolecules. 23(1). 303–315. 21 indexed citations
7.
Julin, Kjersti, et al.. (2021). Chitosomes-In-Chitosan Hydrogel for Acute Skin Injuries: Prevention and Infection Control. Marine Drugs. 19(5). 269–269. 43 indexed citations
8.
Obuobi, Sybil, Kjersti Julin, Elizabeth G. Aarag Fredheim, Mona Johannessen, & Nataša Škalko‐Basnet. (2020). Liposomal delivery of antibiotic loaded nucleic acid nanogels with enhanced drug loading and synergistic anti-inflammatory activity against S. aureus intracellular infections. Journal of Controlled Release. 324. 620–632. 60 indexed citations
9.
Jøraholmen, May Wenche, et al.. (2020). The Antimicrobial Properties of Chitosan Can Be Tailored by Formulation. Marine Drugs. 18(2). 96–96. 47 indexed citations
10.
Julin, Kjersti, et al.. (2019). Liposomes augment biological benefits of curcumin for multitargeted skin therapy. European Journal of Pharmaceutics and Biopharmaceutics. 144. 154–164. 50 indexed citations
11.
Julin, Kjersti, et al.. (2014). Persistent infections with infectious pancreatic necrosis virus (IPNV) of different virulence in Atlantic salmon, Salmo salar L. Journal of Fish Diseases. 38(11). 1005–1019. 32 indexed citations
12.
Julin, Kjersti, et al.. (2012). Study of virulence in field isolates of infectious pancreatic necrosis virus obtained from the northern part of Norway. Journal of Fish Diseases. 36(2). 89–102. 14 indexed citations
13.
Julin, Kjersti, et al.. (2009). Reference genes evaluated for use in infectious pancreatic necrosis virus real-time RT-qPCR assay applied during different stages of an infection. Journal of Virological Methods. 162(1-2). 30–39. 31 indexed citations
14.
Machoň, Ondřej, Mattias Backman, Kjersti Julin, & Stefan Krauß. (2000). Yeast two-hybrid system identifies the ubiquitin-conjugating enzyme mUbc9 as a potential partner of mouse Dac. Mechanisms of Development. 97(1-2). 3–12. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naser Mohammadpour Dounighi Breakdown of academic impact, for papers by Hossein Zolfagharian Breakdown of academic impact, for papers by Yongsheng Ma Breakdown of academic impact, for papers by Chelsea L. Bueter Breakdown of academic impact, for papers by Kyle Kleinbeck Breakdown of academic impact, for papers by Patricia Pérez Esteban Breakdown of academic impact, for papers by Melahat Bağırova Breakdown of academic impact, for papers by Grzegorz Gorczyca Breakdown of academic impact, for papers by Soheila Moradi Bidhendi Breakdown of academic impact, for papers by James Jung
Rankless by CCL
2026